Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out barbiturate exposure. For follow-up testing of a presumptive result, Barbiturates, Urine Quantitative (2012213) is preferred.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Random urine.
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Transfer 4.0 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2.0 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Room temperature.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Breast milk. Pharmaceutical preparation.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Qualitative Enzyme Immunoassay/Quantitative Gas Chromatography-Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Days of the week the test is performed.
Sun-Sat
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-4 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Methodology: Immunoassay
Positive Cutoff: 200 ng/mL
Compliance Category
FDA
Note
Additional information related to the test.
If the specimen screens positive, then Confirmation/Quantitation by GC-MS and/or LC-MS/MS (ARUP test code 2012213) will be added to confirm result. Additional charges apply.
Compare to Pain Management, Barbiturates, Quantitative, with medMatch, Urine; Pain Management, Barbiturates, with Confirmation with medMatch, Urine.
Hotline History
N/A
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
80307; if reflexed, add 80345 (Reflexed Alt Code: G0480 )
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
Quinalbarbitone
Luminal
Amytal
Axocet
Pentobarbital
Tuinal
Amobarbitone
Butalbital
Fioricet
Seconal
Solfoton
Nembutal
Pain Management
Sandoptal
Phenobarbital
Phenobarbitone
Fiorinal
Barbiturates, Urine Screen with Reflex to Quantitation
Connect Sign In
